Table 3.

Partial Spearman correlation of plasma levels of AEA and related N-acylethanolamines with plasma levels of lipopolysaccharide in participants who showed very low and high values (EU/mL) adjusted for body mass index.

	AEA and Related N-acylethanolamines (Peak Area Ratio)
	AEA		AA		DHEA		DGLEA		LEA		Alpha LEA		PEA		PDEA		POEA		OEA		SEA
	rho	p	rho	p	rho	p	rho	p	rho	p	rho	p	rho	p	rho	p	rho	p	rho	p	rho	p
Q1: Low LPS (N = 19)	0.262	0.012	0.228	0.030	0.123	0.246	0.221	0.035	0.404	<0.001	0.428	<0.001	0.451	<0.001	0.234	0.026	0.467	<0.001	0.440	<0.001	0.428	<0.001
Q4: High LPS (N = 21)	−0.464	<0.001	−0.389	<0.001	−0.001	0.992	−0.472	<0.001	−0.300	0.004	0.107	0.315	−0.304	0.003	−0.281	0.007	−0.504	<0.001	−0.408	<0.001	−0.156	0.139

Correlation analyses were performed adjusting for body mass index. Spearman’s correlations coefficient (rho) and p-values (p) obtained from univariate Spearman correlation analyses are provided. The bold indicates p-values < 0.05. Alpha LEA: alpha-Linolenoyl ethanolamide; AA: arachidonic acid; AEA: anandamide; DGLEA: dihomo-gamma-linolenoyl ethanolamide; DHEA: docosahexaenoyl ethanolamide; EU: endotoxins units; LEA: linoleoyl ethanolamide; LPS: lipopolysaccharide; OEA: oleoyl ethanolamine; PEA: palmitoyl ethanolamide; PDEA: pentadecanoyl ethanolamide; POEA: palmitoleoyl ethanolamide; Q: quartile; SEA: stearoyl ethanolamide.